Recently, several cytokines, including TSLP, IL-4/13, and IL-31, have been reported to be involved in AD-associated pruritus, and biological agents targeting these cytokines have been shown to improve pruritus in AD patients (8). This evidence concerns the gene IL4 and Pruritus.